Alice is a Partner of Syncona Investment Management Ltd. She is also Head of Operations at Purespring Therapeutics and works closely with Anaveon. Alice serves as an Observer on the Board of Purespring and Anaveon. Prior to Syncona, Alice was an Investment Banking Analyst within Barclays’ Healthcare M&A team, where she worked on transactions involving healthcare companies. Alice holds a Doctorate degree in Pharmacy from the University of Lille 2 (School of Pharmacy) and a Masters in International Health Policy & Health Economics from the London School of Economics.
Likes
Share It 
